Illumina Inc (ILMN)

203.09
1.86 0.91
NASDAQ : Health Care
Prev Close 204.95
Open 204.94
Day Low/High 201.05 / 205.82
52 Wk Low/High 127.10 / 223.24
Volume 1.07M
Avg Volume 917.00K
Exchange NASDAQ
Shares Outstanding 146.00M
Market Cap 30.57B
EPS 3.10
P/E Ratio 41.96
Div & Yield N.A. (N.A)

Latest News

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina And Telegraph Hill Partners Launch Verogen, Inc. To Drive Adoption Of Next-Generation Sequencing In The Global Forensic Genomics Market

Illumina And Telegraph Hill Partners Launch Verogen, Inc. To Drive Adoption Of Next-Generation Sequencing In The Global Forensic Genomics Market

Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc.

Illumina Becomes #25 Most Shorted Nasdaq 100 Component, Replacing Mattel

The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Azumio Introduces DNA-Based Insights Into Its Fitness Platform

Azumio Introduces DNA-Based Insights Into Its Fitness Platform

Understanding genetic predisposition to food intolerances and injury risks enable Azumio platform users to reach their fitness goals faster

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Slow markets like this demand a less-is-more approach.

Dow Finishes Above 22,000 and Posts Sixth Straight Record as Apple Reaches New Heights

Dow Finishes Above 22,000 and Posts Sixth Straight Record as Apple Reaches New Heights

The Dow clinches 22,000 milestone.

Apple Gains Put Dow on Track for Sixth Straight Record Close

Apple Gains Put Dow on Track for Sixth Straight Record Close

The Dow clinches 22,000 milestone.

Will Illumina Maintain This Feverish Pace? Chart Shows What's Next

Will Illumina Maintain This Feverish Pace? Chart Shows What's Next

With a 12% surge, Illumina is the top gainer in the S&P 500.

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2.

Apple's Strong Gains Put Dow 22,000 Within Reach

Apple's Strong Gains Put Dow 22,000 Within Reach

Stock futures are higher.

Illumina Reports Strong Financial Results For Second Quarter Of Fiscal Year 2017

Illumina Reports Strong Financial Results For Second Quarter Of Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2017.

Kindara Unveils Plan To Revolutionize Women's Health Industry With Kindara DNA

Kindara Unveils Plan To Revolutionize Women's Health Industry With Kindara DNA

New genetic test will pair with Kindara App to help identify nutrition, fitness and wellness insights, launching 2018

Illumina To Announce Second Quarter 2017 Financial Results On Tuesday, August 1, 2017

Illumina To Announce Second Quarter 2017 Financial Results On Tuesday, August 1, 2017

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2017 following the close of market on Tuesday, August 1, 2017.

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the...

Genomics England Adopts Illumina's BaseSpace Variant Interpreter For Cancer

Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the...

Illumina Shines as Another Biotech Winner

Illumina Shines as Another Biotech Winner

Illumina is the number two gainer in the Nasdaq 100 with a 3.7% gain.

Coalition For Access To Prenatal Screening Announces Clinical Advisory Board

Board to provide independent medical perspective on noninvasive prenatal screening

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Files Amended Complaint Against Illumina, Inc. And Senior Officers

The following statement is being issued by Levi & Korsinsky, LLP: On March 30, 2017, United States District Court Judge M.

Illumina To Webcast Live Presentation At The Goldman Sachs Global Healthcare Conference

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 13, 2017.

Illumina Becomes #26 Most Shorted Nasdaq 100 Component, Replacing Automatic Data Processing

The most recent short interest data has been released for the 05/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina Chief Commercial Officer Mark Van Oene (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Mark Van Oene has been named Chief Commercial Officer.

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Illumina To Webcast Live Presentation At The Bank Of America Merrill Lynch Health Care Conference

Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada, on May 18, 2017.

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2017.

Illumina To Announce First Quarter 2017 Financial Results On Tuesday, April 25, 2017

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2017 following the close of market on Tuesday, April 25, 2017.

VeriSeq™ NIPT Solution (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the VeriSeq ™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked...

TheStreet Quant Rating: B (Buy)